Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma

THEODOROS P. VASSILAKOPOULOS, MARIE-CHRISTINE KYRTSONIS, ARGIROULA PAPADOGIANNIS, GIANPAOLO NADALI, MARIA K. ANGELOPOULOU, TATIANA TZENOU, MARIA N. DIMOPOULOU, MARINA P. SIAKANTARIS, FLORA N. KONTOPIDOU, CHRISTINA KALPADAKIS, STYLIANI I. KOKORIS, EVANGELIA M. DIMITRIADOU, PANAYIOTIS TSAFTARIDIS, GIOVANNI PIZZOLO and GERASSIMOS A. PANGALIS
Anticancer Research November 2005, 25 (6C) 4743-4746;
THEODOROS P. VASSILAKOPOULOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIE-CHRISTINE KYRTSONIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARGIROULA PAPADOGIANNIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIANPAOLO NADALI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA K. ANGELOPOULOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TATIANA TZENOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA N. DIMOPOULOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARINA P. SIAKANTARIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FLORA N. KONTOPIDOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHRISTINA KALPADAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STYLIANI I. KOKORIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVANGELIA M. DIMITRIADOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PANAYIOTIS TSAFTARIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GIOVANNI PIZZOLO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERASSIMOS A. PANGALIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pangalis@med.uoa.gr
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 6C 4743-4746
PubMed 
16334170

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 24, 2005
  • Accepted July 28, 2005
  • Published online November 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. THEODOROS P. VASSILAKOPOULOS1,
  2. MARIE-CHRISTINE KYRTSONIS1,
  3. ARGIROULA PAPADOGIANNIS1,
  4. GIANPAOLO NADALI2,
  5. MARIA K. ANGELOPOULOU1,
  6. TATIANA TZENOU1,
  7. MARIA N. DIMOPOULOU1,
  8. MARINA P. SIAKANTARIS1,
  9. FLORA N. KONTOPIDOU1,
  10. CHRISTINA KALPADAKIS1,
  11. STYLIANI I. KOKORIS1,
  12. EVANGELIA M. DIMITRIADOU1,
  13. PANAYIOTIS TSAFTARIDIS1,
  14. GIOVANNI PIZZOLO2 and
  15. GERASSIMOS A. PANGALIS1
  1. 1First Department of Internal Medicine and Department of Haematology, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece
  2. 2Department of Clinical and Experimental Medicine, Section of Haematology, University of Verona, Italy
  1. Correspondence to: G.A. Pangalis, Chairman, First Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laikon University Hospital, 17 Aghiou Thomas St., Athens 11527, Greece. Tel: 00301-7771161, Fax: 0030210-7788830, e-mail: pangalis{at}med.uoa.gr

Statistics from Altmetric.com

Cited By...

  • 28 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 25 (6C)
Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma
THEODOROS P. VASSILAKOPOULOS, MARIE-CHRISTINE KYRTSONIS, ARGIROULA PAPADOGIANNIS, GIANPAOLO NADALI, MARIA K. ANGELOPOULOU, TATIANA TZENOU, MARIA N. DIMOPOULOU, MARINA P. SIAKANTARIS, FLORA N. KONTOPIDOU, CHRISTINA KALPADAKIS, STYLIANI I. KOKORIS, EVANGELIA M. DIMITRIADOU, PANAYIOTIS TSAFTARIDIS, GIOVANNI PIZZOLO, GERASSIMOS A. PANGALIS
Anticancer Research Nov 2005, 25 (6C) 4743-4746;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma
THEODOROS P. VASSILAKOPOULOS, MARIE-CHRISTINE KYRTSONIS, ARGIROULA PAPADOGIANNIS, GIANPAOLO NADALI, MARIA K. ANGELOPOULOU, TATIANA TZENOU, MARIA N. DIMOPOULOU, MARINA P. SIAKANTARIS, FLORA N. KONTOPIDOU, CHRISTINA KALPADAKIS, STYLIANI I. KOKORIS, EVANGELIA M. DIMITRIADOU, PANAYIOTIS TSAFTARIDIS, GIOVANNI PIZZOLO, GERASSIMOS A. PANGALIS
Anticancer Research Nov 2005, 25 (6C) 4743-4746;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Heparanase promotes Syndecan-1 expression to mediate fibrillar collagen and mammographic density in human breast tissue cultured ex vivo
  • Google Scholar

More in this TOC Section

  • Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
  • Intratumoral Injection of Allogeneic NK Cell With Chemotherapy in a Triple-negative Breast Cancer Preclinical Model
  • Efficacy of Pembrolizumab as Second or Third-line Therapy for Local Advanced and Metastatic Urothelial Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire